Evidence map›Paper›PMID 35082440›Full record

ArticleMolecular psychiatry2022

Assessment of early neurocognitive functioning increases the accuracy of predicting chronic PTSD risk.

Katharina Schultebraucks, Ziv Ben-Zion, Roee Admon, Jackob Nimrod Keynan, Israel Liberzon, Talma Hendler, Arieh Y Shalev

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. High-density EEG sleep correlates of cognitive and affective impairment at 12-month follow-up after COVID-19.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Katharina Schultebraucks *Department of Emergency Medicine, Columbia University Irving Medical Center, New York, NY, USA. ks3796@cumc.columbia.edu.ORCID http://orcid.org/0000-0001-5085-8249
Ziv Ben-Zion *Sagol Brain Institute Tel-Aviv, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.ORCID http://orcid.org/0000-0003-3629-5851
Roee AdmonSchool of Psychological Sciences, University of Haifa, Haifa, Israel.ORCID http://orcid.org/0000-0002-9886-5111
Jackob Nimrod KeynanSagol Brain Institute Tel-Aviv, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Israel LiberzonTexas A&M Health, Bryan, TX, USA.ORCID http://orcid.org/0000-0002-4990-556X
Talma HendlerSagol Brain Institute Tel-Aviv, Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Arieh Y ShalevDepartment of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
Tel Aviv University · ILColumbia University Irving Medical Center · USNew York University · USTexas A&M Health Science Center · USUniversity of Haifa · IL

Funding

Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)R01MH129856 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Katharina Schultebraucks · 2022 to 2026
$4.1M
Early Signs:digital phenotyping to identify digital biomarkers for predicting burnout and cognitive functioning in ED clinicians (Early Signs)R01HL156134 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SCHULTEBRAUCKS, KATHARINA · 2021 to 2025
$3.6M
Neurobehavioral Moderators of Post-traumatic Disease TrajectoriesR01MH103287 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHALEV, ARIEH Y · 2014 to 2018
$2.7M
NHLBI NIH HHS R01 HL156134NIMH NIH HHS R01 MH103287NIMH NIH HHS R01 MH129856
6 · The paper itself

Abstract

Post-traumatic stress disorder (PTSD) is a protracted and debilitating consequence of traumatic events. Identifying early predictors of PTSD can inform the disorder's risk stratification and prevention. We used advanced computational models to evaluate the contribution of early neurocognitive performance measures to the accuracy of predicting chronic PTSD from demographics and early clinical features. We consecutively enrolled adult trauma survivors seen in a general hospital emergency department (ED) to a 14-month long prospective panel study. Extreme Gradient Boosting algorithm evaluated the incremental contribution to 14 months PTSD risk of demographic variables, 1-month clinical variables, and concurrent neurocognitive performance. The main outcome variable was PTSD diagnosis, 14 months after ED admission, obtained by trained clinicians using the Clinician-Administered PTSD Scale (CAPS). N = 138 trauma survivors (mean age = 34.25 ± 11.73, range = 18-64; n = 73 [53%] women) were evaluated 1 month after ED admission and followed for 14 months, at which time n = 33 (24%) met PTSD diagnosis. Demographics and clinical variables yielded a discriminatory accuracy of AUC = 0.68 in classifying PTSD diagnostic status. Adding neurocognitive functioning improved the discriminatory accuracy (AUC = 0.88); the largest contribution emanating from poorer cognitive flexibility, processing speed, motor coordination, controlled and sustained attention, emotional bias, and higher response inhibition, and recall memory. Impaired cognitive functioning 1-month after trauma exposure is a significant and independent risk factor for PTSD. Evaluating cognitive performance could improve early screening and prevention.

Indexed as

Stress Disorders, Post-TraumaticAdultAttentionChild, PreschoolEmotionsFemaleHumansInfantMaleMental RecallProspective Studies

Identifiers

PMID35082440
PMCPMC11129320
OpenAlexW4210407740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.